EIKO
EIKO LIFESCIENCES financials
- Market cap
- ₹71 Cr
Quarterly results
Q1 FY27: revenue up 56.4%, net profit up 36.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 7 | 11 | 11 | 12 +43% | 12 +60% | 18 +63% | 17 +56% |
| EBITDA | 0 | 1 | 1 | 2 | 2 +312% | 2 +198% | 2 +71% | 2 +28% |
| Net profit | 0 | 0 | 1 | 1 | 1 +361% | 1 +240% | 2 +20% | 2 +36% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −12.6% 1Y
1Y: ₹52.49 on 9 Sept 2025 → ₹45.9. High ₹62.03 (4 Nov 2025), low ₹45.38 (4 Sept 2026).
Financials, as filed
Revenue grew 125.6% a year over 2 years, FY20 to FY26. Operating margin widened to 14.1%.
| Year ending | FY20 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹10 Cr | ₹38 Cr | ₹53 Cr |
| Operating profit | ₹-5 Cr | ₹3 Cr | ₹7 Cr |
| Operating margin | -44.0% | 7.4% | 14.1% |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Net profit | ₹-4 Cr | ₹2 Cr | ₹5 Cr |
| Net margin | -35.0% | 6.2% | 10.1% |
| Cash from operations | ₹-0 Cr | ₹3 Cr | ₹2 Cr |
| Free cash flow | ₹-1 Cr | ₹-8 Cr | ₹2 Cr |
| ROCE | -105.4% | — | 11.1% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY18 | FY19 | FY20 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity capital | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹14 Cr | ₹14 Cr |
| Reserves | ₹2 Cr | ₹1 Cr | ₹-1 Cr | ₹45 Cr | ₹54 Cr |
| Borrowings | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹5 Cr |
| Other liabilities | ₹4 Cr | ₹3 Cr | ₹7 Cr | ₹5 Cr | ₹16 Cr |
| Total liabilities | ₹11 Cr | ₹9 Cr | ₹12 Cr | ₹65 Cr | ₹89 Cr |
| Fixed assets | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹23 Cr | ₹22 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹3 Cr | ₹2 Cr | ₹0 Cr | ₹7 Cr | ₹15 Cr |
| Other assets | ₹6 Cr | ₹6 Cr | ₹10 Cr | ₹35 Cr | ₹52 Cr |
| Total assets | ₹11 Cr | ₹9 Cr | ₹12 Cr | ₹65 Cr | ₹89 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters added +3.17 pp while the public trimmed −3.17 pp. The shareholder count shrank 9% to 3,019.
- Promoters
- 39.9%
- Public
- 60.1%
Since Jun 2025
- Promoters +3.17 pp
- Public −3.17 pp
How it drifted, 12 quarters
Over this window promoters went from 24.2% to 39.9% — +15.7 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 24.2%, Public 75.8%.Dec '23: Promoters 24.2%, Public 75.8%.Mar '24: Promoters 24.2%, Public 75.8%.Jun '24: Promoters 24.4%, Public 75.6%.Sep '24: Promoters 24.4%, Public 75.6%.Dec '24: Promoters 31.3%, Public 68.7%.Mar '25: Promoters 36.2%, Public 63.8%.Jun '25: Promoters 36.7%, Public 63.3%.Sep '25: Promoters 37.2%, Public 62.8%.Dec '25: Promoters 37.2%, Public 62.8%.Mar '26: Promoters 39.9%, Public 60.1%.Jun '26: Promoters 39.9%, Public 60.1%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Sushila Paraskumar Daga +1.12 pp 2.78% held
- Ashika Global Finance Private Limited +0.06 pp 4.19% held
The same filing shows 1 holder trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of EIKO LIFESCIENCES LIMITED above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Lenus Finvest Private Limited | 17.71% | unchanged |
| Laxmikant Kabra (Huf) | 9.90% | unchanged |
| 2B Black Bio Llp | 9.66% | unchanged |
| Bhavesh Dhirajlal Tanna | 5.86% | unchanged |
| Siddhant Laxmikant Kabra | 5.63% | unchanged |
| Ashika Global Finance Private Limited | 4.19% | +0.06 pp |
| Ashok Vishwanath Hiremath | 3.72% | unchanged |
| Sushila Paraskumar Daga | 2.78% | +1.12 pp |
| Sivanesan Sellappan | 2.02% | unchanged |
| Joyanta Kumar Jana | 1.99% | unchanged |
| Parshva Kumar Daga | 1.68% | unchanged |
| Bhavinkumar Vinaychand Shah | 1.35% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse EIKO LIFESCIENCES LIMITED
Guides on how to read this kind of business and the numbers that matter.